Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price ...

A loophole that allowed compounding pharmacies to make cheaper, generic version of drugs like Ozempic and Wegovy has closed.

Starting today, pharmacies can no longer make cheaper alternatives to popular weight loss drugs, driving up costs for ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

These meds go by the brand names Ozempic, Wegovy and Mounjaro. General practitioners, cosmetic surgeons, and many other medical specialists now commonly find themselves answering questions from ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Bariatric surgeries: These are operations that remove or bypass part of the stomach for the purpose of losing weight and ...

Costly drugs: The drugs prescribed to fight obesity have been driving up the cost of Medi-Cal, the state program that ...